"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry.
Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible
insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
Samuel Lesko has more than 20 years experiences in running AFM over variety of applications.
After obtaining a PhD at Burgundy university on colloidal force measurement in cement, he started his career at Veeco Instruments as French Applications Scientists before to continue on supporting Bio Applications AFM European wide. He is since 2007 Applications manager for Europe, Middle East and Africa. Recently, his position expanded to Latin America.
Paul Morris is the Director of Professional Advancement for Specsavers Opticians in the UK and Ireland. The role involves furthering clinical scope, professional services, standards, training and forming future strategy for the group. He previously held the role of Director of Optometry Advancement.
The World Health Organisation marked World Pneumonia Day on November 12th to promote interventions to protect against, prevent and treat pneumonia. The condition is a worldwide killer affecting people of all ages, however the ‘aging population’ is at an increased risk.
There are about 77,000 people known to have cystic fibrosis. That's from the various cystic fibrosis registries available globally. The World Health Organization suggests that this number may be low, because there's no reporting on cystic fibrosis from the developing world. The accepted number, at the moment, is about 80,000. That's the one that is used for most of the work that's being done on cystic fibrosis.
Autism is a clinical diagnosis. There is no one test to diagnose autism. Depending on the type of medical professional diagnosing, typically the DSM-V (standard classification of mental disorders used by mental health professionals in the U.S.) is used to diagnose by primary care physicians, neurologists, and psychiatrists.
There are two problems that pathologists face today. The first is, that a pathologist’s diagnosis using tissue sections is becoming more complex. There are many more biomarkers, and clinicians now ask for a more precise diagnosis. Secondly, the number of pathologists worldwide is declining every day, as the profession is often overlooked in favor of other specializations.
Leveraging the mass production benefit that MultiBrain® technology brings to neurohistology, NSA can accelerate the R&D preclinical and safety assessment processes many fold and perform them less expensively. This results in faster times for a potential drug to move from R&D to clinical trials and sooner for use in people.
For many years, I was a psychologist at a very large US university mental health center and we constantly had more people seeking help than we could possibly accommodate. That is a ubiquitous problem across lots of sectors, including community mental health and private practice in any rural area.
Jules Wyss is the head of the quality assurance laboratory at the largest brewery in Switzerland, the Feldschlösschen brewery in Rheinfelden. The master brewer and beverage technologist helped to set up the QA lab from 1991 onward.
TRPS is the most powerful and accurate nanoparticle measurement and analysis method on the market. It’s a non-optical technique using precise single particle measurement to provide certainty detail on particle size distribution, surface charge and charge distribution, and particle concentration (count).
The report set out the NHS’ intentions of routinizing whole genome sequencing. It is particularly focused towards rare diseases and cancers, although conditions such as obesity, bacterial and other infections are also included.
Women start off with breasts that are predominately full of milk-producing glandular tissue (“dense tissue”). That tissue slowly changes to fat as the woman ages with an acceleration in that change over menopause.
We imagine a world where mobility is never an impairment: a world where limitations to natural movement caused by injury, disorder or disability are restored and where boundaries to human performance can be broken.
Species identification is important for ecological research and in particular to study the impact of natural hazards or environmental pollutants present, because it’s possible to determine the general health of the ecosystem through the diversity of life that are found in a given area.
The brain is very plastic, which means that the brain is able to adapt to new signals. In the case of bionic vision restoration, the photoreceptors have died, the brain is not receiving anything biologically, and you are going to then send something which is artificial, prosthetic, and has been created outside the body.
Peerbridge Health has the vision to remove all wires associated with monitoring patients. For example, typically, electrocardiogram (ECG) monitoring systems have a multitude of wires. They started building a wireless ECG monitoring system called the Peerbridge Cor™ to improve ECG monitoring from the ground up.
The main challenges in optimizing beer shelf life is that most manufacturers can only perform accelerated shelf life testing on packaged beer. So, it's almost impossible to determine where in the process you've had a positive or a negative impact on the freshness of the beer.
Victories Over Cancer is about enabling those affected by cancer to enjoy more of life’s meaning full moments and making cancer more manageable. At Janssen, we're really thinking about the elimination of cancer, and we take a very deliberate approach to that.
There are two main challenges and both relate to manufacturing. The first one is to make sure you can manufacture therapies with reasonable costs and the second one is to make sure that you can balance the capacity you need with the demands.
This test, which we have branded SelectMDx for Prostate Cancer, came with the acquisition of a company in the Netherlands called NovioGendix. They developed a prototype assay, so they did most of the heavy lifting in terms of discovering the two specific biomarkers that are currently in the product. These biomarkers are tuned towards the detection of what I call clinically significant prostate cancer.